- Home
- GOVX vs ELBM Comparison
GOVX vs ELBM Comparison
Compare GOVX & ELBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- ELBM
- Stock Information
- Founded
- GOVX 2001
- ELBM 2011
- Country
- GOVX United States
- ELBM Canada
- Employees
- GOVX N/A
- ELBM N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- ELBM Industrial Machinery/Components
- Sector
- GOVX Health Care
- ELBM Miscellaneous
- Exchange
- GOVX Nasdaq
- ELBM Nasdaq
- Market Cap
- GOVX 15.5M
- ELBM 18.5M
- IPO Year
- GOVX N/A
- ELBM N/A
- Fundamental
- Price
- GOVX $0.45
- ELBM $1.08
- Analyst Decision
- GOVX Strong Buy
- ELBM Strong Buy
- Analyst Count
- GOVX 5
- ELBM 1
- Target Price
- GOVX $12.40
- ELBM $2.20
- AVG Volume (30 Days)
- GOVX 2.4M
- ELBM 708.1K
- Earning Date
- GOVX 08-05-2025
- ELBM 08-13-2025
- Dividend Yield
- GOVX N/A
- ELBM N/A
- EPS Growth
- GOVX N/A
- ELBM N/A
- EPS
- GOVX N/A
- ELBM N/A
- Revenue
- GOVX $5,591,576.00
- ELBM N/A
- Revenue This Year
- GOVX N/A
- ELBM N/A
- Revenue Next Year
- GOVX N/A
- ELBM N/A
- P/E Ratio
- GOVX N/A
- ELBM N/A
- Revenue Growth
- GOVX N/A
- ELBM N/A
- 52 Week Low
- GOVX $0.43
- ELBM $0.91
- 52 Week High
- GOVX $11.18
- ELBM $2.83
- Technical
- Relative Strength Index (RSI)
- GOVX 28.21
- ELBM 52.48
- Support Level
- GOVX $0.43
- ELBM $1.05
- Resistance Level
- GOVX $0.98
- ELBM $1.10
- Average True Range (ATR)
- GOVX 0.15
- ELBM 0.05
- MACD
- GOVX -0.06
- ELBM 0.00
- Stochastic Oscillator
- GOVX 2.07
- ELBM 46.15
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About ELBM Electra Battery Materials Corporation
Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry.